Icon

PERFOROMIST (nda022007)- (0.02MG/2ML)

FORMOTEROL FUMARATE MYLAN SPECLT
0.02MG/2ML
Yes Yes
2021-Jun-22 Expired
None None
None No
PERFOROMIST Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist) indicated for: • Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
6 0 6
Total Other Developers 24
Drugs with Suitability No
0.02MG/2ML ** ** - - 6
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** ****** *** *** ****** ********** ******* *********** ***** **** *****, ********** **** ********** ******, ******* *****, *******, ******** *** ***, ****** ******* (***) ***
****** ******* ******** ****************** **** *********** **********., ********-******, - *****, ******* (***) ***
****** ******** ****** *** ******** ****************** **** *********** **********., ********-******, - *****, ******* (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.